By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


INSYS Therapeutics 

10220 South 51st Street
Suite 2
Phoenix  Arizona  85044  U.S.A.
Phone: 602-910-2617 Fax: 602-910-2627


Company News
INSYS Therapeutics In-Licenses Cannabinoid Inhalation Technology 9/28/2015 1:08:19 PM
INSYS Therapeutics To Present At 10th Annual Wells Fargo Healthcare Conference 9/3/2015 11:40:42 AM
INSYS Therapeutics Files Citizen Petition With The Drug Enforcement Administration (DEA) To Reschedule Its Synthetic Pharmaceutical Cannabidiol (CBD) 8/19/2015 1:47:09 PM
INSYS Therapeutics' Dronabinol Oral Solution NDA Accepted For Filing By FDA 8/17/2015 10:48:07 AM
INSYS Therapeutics Reports Second Quarter 2015 Results 8/7/2015 9:13:58 AM
INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol For The Treatment Of Infantile Spasms 8/4/2015 11:26:03 AM
INSYS Therapeutics To Report Second Quarter 2015 Results 7/24/2015 11:18:35 AM
INSYS Therapeutics To Present At JMP Securities Life Sciences Conference 2015 6/18/2015 10:20:42 AM
INSYS Therapeutics Completes Two-for-One Stock Split Through Stock Dividend 6/9/2015 10:04:04 AM
INSYS Therapeutics Submits NDA For Dronabinol Oral Solution 6/2/2015 10:59:12 AM